Advisor Partners LLC Charles River Laboratories International, Inc. Transaction History

Advisor Partners LLC

  • $1.42 Billion
  • Q2 2022

A detailed history of Advisor Partners LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Advisor Partners LLC holds 1,790 shares of CRL stock, worth $350,428. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,790
Previous 1,538 16.38%
Holding current value
$350,428
Previous $437,000 12.36%
% of portfolio
0.03%
Previous 0.03%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
BUY
$204.13 - $302.4 $51,440 - $76,204
252 Added 16.38%
1,790 $383,000
Q1 2022

Apr 27, 2022
BUY
$255.51 - $362.11 $1,788 - $2,534
7 Added 0.46%
1,538 $437,000
Q4 2021

Feb 04, 2022
SELL
$351.38 - $448.68 $5,622 - $7,178
-16 Reduced 1.03%
1,531 $577,000
Q3 2021

Nov 15, 2021
SELL
$372.64 - $458.3 $31,301 - $38,497
-84 Reduced 5.15%
1,547 $638,000
Q2 2021

Aug 12, 2021
BUY
$294.17 - $371.65 $15,591 - $19,697
53 Added 3.36%
1,631 $603,000
Q1 2021

Jun 01, 2021
BUY
$249.67 - $299.48 $5,243 - $6,289
21 Added 1.35%
1,578 $457,000
Q4 2020

Feb 17, 2021
BUY
$222.0 - $252.62 $9,768 - $11,115
44 Added 2.91%
1,557 $389,000
Q3 2020

Nov 19, 2020
SELL
$175.56 - $226.45 $34,585 - $44,610
-197 Reduced 11.52%
1,513 $343,000
Q2 2020

Aug 13, 2020
BUY
$118.84 - $189.72 $2,971 - $4,743
25 Added 1.48%
1,710 $298,000
Q1 2020

May 15, 2020
SELL
$98.9 - $178.34 $11,274 - $20,330
-114 Reduced 6.34%
1,685 $212,000
Q4 2019

Jan 24, 2020
SELL
$126.05 - $152.76 $9,579 - $11,609
-76 Reduced 4.05%
1,799 $286,000
Q3 2019

Oct 16, 2019
BUY
$125.07 - $143.67 $2,501 - $2,873
20 Added 1.08%
1,875 $248,000
Q2 2019

Jul 26, 2019
SELL
$123.4 - $148.55 $12,586 - $15,152
-102 Reduced 5.21%
1,855 $263,000
Q1 2019

Apr 23, 2019
SELL
$104.82 - $146.73 $17,400 - $24,357
-166 Reduced 7.82%
1,957 $284,000
Q4 2018

Jan 29, 2019
BUY
$105.09 - $137.23 $7,566 - $9,880
72 Added 3.51%
2,123 $240,000
Q3 2018

Nov 06, 2018
SELL
$112.11 - $134.54 $672 - $807
-6 Reduced 0.29%
2,051 $276,000
Q2 2018

Jul 25, 2018
BUY
$102.37 - $117.25 $15,969 - $18,291
156 Added 8.21%
2,057 $231,000
Q1 2018

May 03, 2018
SELL
$98.19 - $115.2 $24,940 - $29,260
-254 Reduced 11.79%
1,901 $203,000
Q4 2017

Jan 26, 2018
BUY
$100.43 - $118.09 $401 - $472
4 Added 0.19%
2,155 $233,000
Q3 2017

Nov 03, 2017
BUY
$96.72 - $109.26 $208,044 - $235,018
2,151
2,151 $232,000

Others Institutions Holding CRL

# of Institutions
696
Shares Held
52.3M
Call Options Held
259K
Put Options Held
463K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Advisor Partners LLC Portfolio

Follow Advisor Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email